Redwood Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021
February 16, 2022 at 02:30 am EST
Redwood Pharma AB reported earnings results for the fourth quarter and full year ended December 31, 2021. For the fourth quarter, the company reported net loss was SEK 3.6 million compared to SEK 4.31 million a year ago. Basic loss per share from continuing operations was SEK 0.17 compared to SEK 0.28 a year ago.
For the full year, net loss was SEK 20.84 million compared to SEK 14.53 million a year ago. Basic loss per share from continuing operations was SEK 0.71 compared to SEK 0.97 a year ago.